Pricing Log in Create free account
Saturday 17 October 2026 Export VTRS’s income statement to Excel — free account

Viatris Inc.

VTRS Healthcare Drug Manufacturers Specialty & Generic

Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.88%, EPS fell 2,464.1%, free cash flow grew 101.1% and total debt fell 18.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years.

18.66 0.44 +2.41%
Market cap
$20.9B
P/E
0.0×
Fwd P/E
61.1×
Dividend yield
2.57%
F-score
4/9
Altman Z
0.61
Beneish M
−3.29
Dividend safety
37/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Viatris Inc. (VTRS) Debt to equity

Alert me on Debt to equity

Viatris Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 0.9×, down 0.2× from fiscal 2025 (1.1×). Over the past ten years it has ranged from 0.8× (fiscal 2015) to 1.5× (fiscal 2016); the current reading is higher than 45% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.0× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 1.1× 30.18%
FY2024 0.9× (3.17%)
FY2023 0.9× (3.15%)
FY2022 0.9× (18.81%)
FY2021 1.1× (8.69%)
FY2020 1.2× 7.16%
FY2019 1.2× 1.05%
FY2018 1.1× (4.97%)
FY2017 1.2× (21.11%)
FY2016 1.5× 101.28%

Quarterly newest first

Period Debt to equity Change
Jun 2026 0.9× (4.32%)
Mar 2026 1.0× (0.12%)
Dec 2025 1.0× (8.32%)
Sep 2025 1.1× 2.04%
42 more quarters

Against its own ten years

Low 0.8× High 1.5×
Ten-year median 1.1×
Current reading's percentile 45

Debt to equity against peers

Company Debt to equity
NBIX Neurocrine Biosciences, Inc. compare 0.0×
UTHR United Therapeutics Corporation compare 0.0×
RDY Dr. Reddy's Laboratories Ltd compare 0.2×
HLN Haleon PLC Sponsored ADR compare 0.5×
ELAN Elanco Animal Health Incorporated compare 0.6×
TAK Takeda Pharmaceutical Co. compare 0.7×
VTRS Viatris Inc. 0.9×
TEVA Teva Pharmaceutical Industries Ltd. compare 2.1×
ZTS Zoetis Inc. compare 2.9×
Drug Manufacturers Specialty & Generic industry median 0.0×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on VTRS